Harold Clinton Eugene Kluender

Title: Harold Clinton Eugene Kluender: Innovator in Matrix Metalloprotease Inhibitors

Introduction

Harold Clinton Eugene Kluender is a notable inventor based in Trumbull, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of matrix metalloprotease inhibitors. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

Kluender holds a patent for "Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors." This patent highlights his expertise in creating compounds that can potentially aid in the treatment of diseases related to tissue remodeling and inflammation. He has 1 patent to his name, reflecting his focused contributions to this specialized area.

Career Highlights

Kluender is associated with Bayer Corporation, a leading global enterprise in the pharmaceutical and life sciences sector. His role at Bayer has allowed him to work on cutting-edge research and development projects, contributing to the advancement of medical science. His dedication to innovation is evident in his patent work and ongoing research efforts.

Collaborations

Throughout his career, Kluender has collaborated with esteemed colleagues, including David R Brittelli and William R Schoen. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Harold Clinton Eugene Kluender exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the realm of matrix metalloprotease inhibitors, underscore the vital role of inventors in advancing medical science.